⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
JSPR
Pomerantz LLP Moves Forward with Class Action Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
JSPR
Pomerantz LLP Moves Forward with Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Launches Securities Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
JSPR
Pomerantz LLP Moves Forward with Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Launches Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR